Literature DB >> 22253254

Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten.

Nina Raben1, Amanda Wong, Evelyn Ralston, Rachel Myerowitz.   

Abstract

Macroautophagy (often referred to as autophagy) is an evolutionarily conserved intracellular system by which macromolecules and organelles are delivered to lysosomes for degradation and recycling. Autophagy is robustly induced in response to starvation in order to generate nutrients and energy through the lysosomal degradation of cytoplasmic components. Constitutive, basal autophagy serves as a quality control mechanism for the elimination of aggregated proteins and worn-out or damaged organelles, such as mitochondria. Research during the last decade has made it clear that malfunctioning or failure of this system is associated with a wide range of human pathologies and age-related diseases. Our recent data provide strong evidence for the role of autophagy in the pathogenesis of Pompe disease, a lysosomal glycogen storage disease caused by deficiency of acid alpha-glucosidase (GAA). Large pools of autophagic debris in skeletal muscle cells can be seen in both our GAA knockout model and patients with Pompe disease. In this review, we will focus on these recent data, and comment on the not so recent observations pointing to the involvement of autophagy in skeletal muscle damage in Pompe disease. Published 2012 Wiley Periodicals, Inc. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253254      PMCID: PMC3265635          DOI: 10.1002/ajmg.c.31317

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  50 in total

Review 1.  Eaten alive: a history of macroautophagy.

Authors:  Zhifen Yang; Daniel J Klionsky
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

2.  Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism.

Authors:  Sixin Jiang; Brigitte Heller; Vincent S Tagliabracci; Lanmin Zhai; Jose M Irimia; Anna A DePaoli-Roach; Clark D Wells; Alexander V Skurat; Peter J Roach
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

3.  Impaired organization and function of myofilaments in single muscle fibers from a mouse model of Pompe disease.

Authors:  Sengen Xu; Mikhail Galperin; Gary Melvin; Robert Horowits; Nina Raben; Paul Plotz; Leepo Yu
Journal:  J Appl Physiol (1985)       Date:  2010-03-11

4.  Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy.

Authors:  J Julie Wu; Celia Quijano; Edmund Chen; Hongjun Liu; Liu Cao; Maria M Fergusson; Ilsa I Rovira; Sarah Gutkind; Mathew P Daniels; Masaaki Komatsu; Toren Finkel
Journal:  Aging (Albany NY)       Date:  2009-04-09       Impact factor: 5.682

5.  Pompe disease in infants: improving the prognosis by newborn screening and early treatment.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Beth L Thurberg; Shu-Chuan Chiang; Xiaokui Kate Zhang; Joan Keutzer; Ai-Chu Huang; Mei-Hwan Wu; Pei-Hsin Huang; Fuu-Jen Tsai; Yuan-Tsong Chen; Wuh-Liang Hwu
Journal:  Pediatrics       Date:  2009-12       Impact factor: 7.124

Review 6.  Pompe's disease.

Authors:  Ans T van der Ploeg; Arnold J J Reuser
Journal:  Lancet       Date:  2008-10-11       Impact factor: 79.321

7.  Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.

Authors:  Yin-Hsiu Chien; Shu-Chuan Chiang; Xiaokui Kate Zhang; Joan Keutzer; Ni-Chung Lee; Ai-Chu Huang; Chun-An Chen; Mei-Hwan Wu; Pei-Hsin Huang; Fu-Jen Tsai; Yuan-Tsong Chen; Wuh-Liang Hwu
Journal:  Pediatrics       Date:  2008-06-02       Impact factor: 7.124

8.  Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles.

Authors:  Eva Masiero; Marco Sandri
Journal:  Autophagy       Date:  2010-02-06       Impact factor: 16.016

9.  When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease.

Authors:  Nina Raben; Rebecca Baum; Cynthia Schreiner; Shoichi Takikita; Noboru Mizushima; Evelyn Ralston; Paul Plotz
Journal:  Autophagy       Date:  2009-01-30       Impact factor: 16.016

Review 10.  Mammalian autophagy: core molecular machinery and signaling regulation.

Authors:  Zhifen Yang; Daniel J Klionsky
Journal:  Curr Opin Cell Biol       Date:  2009-12-23       Impact factor: 8.382

View more
  45 in total

Review 1.  Metabolism and Skeletal Muscle Homeostasis in Lung Disease.

Authors:  Ermelinda Ceco; Samuel E Weinberg; Navdeep S Chandel; Jacob I Sznajder
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

Review 2.  Autophagy at the crossroads of catabolism and anabolism.

Authors:  Jasvinder Kaur; Jayanta Debnath
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07-15       Impact factor: 94.444

Review 3.  Challenges in treating Pompe disease: an industry perspective.

Authors:  Hung V Do; Richie Khanna; Russell Gotschall
Journal:  Ann Transl Med       Date:  2019-07

4.  36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry.

Authors:  Olivier Scheidegger; Daniela Leupold; Rafael Sauter; Oliver Findling; Kai Michael Rösler; Thomas Hundsberger
Journal:  J Neurol       Date:  2018-09-19       Impact factor: 4.849

Review 5.  Molecular regulation of autophagy and its implications for metabolic diseases.

Authors:  Stefan W Ryter; Ja Kun Koo; Augustine M K Choi
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-07       Impact factor: 4.294

6.  Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.

Authors:  Takahiro Yonekawa; May Christine V Malicdan; Anna Cho; Yukiko K Hayashi; Ikuya Nonaka; Toshiki Mine; Takeshi Yamamoto; Ichizo Nishino; Satoru Noguchi
Journal:  Brain       Date:  2014-07-24       Impact factor: 13.501

Review 7.  Autophagy in T-cell development, activation and differentiation.

Authors:  Alisha W Bronietzki; Marc Schuster; Ingo Schmitz
Journal:  Immunol Cell Biol       Date:  2014-10-07       Impact factor: 5.126

8.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Kunil K Raval; Ran Tao; Brent E White; Willem J De Lange; Chad H Koonce; Junying Yu; Priya S Kishnani; James A Thomson; Deane F Mosher; John C Ralphe; Timothy J Kamp
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

Review 9.  Mechanisms for fiber-type specificity of skeletal muscle atrophy.

Authors:  Yichen Wang; Jeffrey E Pessin
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

10.  Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapy.

Authors:  A Broomfield; J Fletcher; J Davison; N Finnegan; M Fenton; A Chikermane; C Beesley; K Harvey; E Cullen; C Stewart; S Santra; S Vijay; M Champion; L Abulhoul; S Grunewald; A Chakrapani; M A Cleary; S A Jones; A Vellodi
Journal:  J Inherit Metab Dis       Date:  2015-10-26       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.